- Home
- DDL vs MRVI Comparison
DDL vs MRVI Comparison
Compare DDL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- MRVI
- Stock Information
- Founded
- DDL 2014
- MRVI 2020
- Country
- DDL China
- MRVI United States
- Employees
- DDL N/A
- MRVI N/A
- Industry
- DDL Catalog/Specialty Distribution
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- MRVI Health Care
- Exchange
- DDL Nasdaq
- MRVI Nasdaq
- Market Cap
- DDL 731.2M
- MRVI 795.7M
- IPO Year
- DDL 2021
- MRVI 2020
- Fundamental
- Price
- DDL $3.70
- MRVI $4.11
- Analyst Decision
- DDL Sell
- MRVI Buy
- Analyst Count
- DDL 1
- MRVI 10
- Target Price
- DDL $1.15
- MRVI $10.28
- AVG Volume (30 Days)
- DDL 507.8K
- MRVI 2.4M
- Earning Date
- DDL 03-03-2025
- MRVI 02-25-2025
- Dividend Yield
- DDL N/A
- MRVI N/A
- EPS Growth
- DDL N/A
- MRVI N/A
- EPS
- DDL 0.13
- MRVI N/A
- Revenue
- DDL $3,158,412,712.00
- MRVI $276,920,000.00
- Revenue This Year
- DDL $17.81
- MRVI N/A
- Revenue Next Year
- DDL $16.81
- MRVI $1.93
- P/E Ratio
- DDL $28.42
- MRVI N/A
- Revenue Growth
- DDL 4.61
- MRVI N/A
- 52 Week Low
- DDL $1.08
- MRVI $3.93
- 52 Week High
- DDL $4.79
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- DDL 62.25
- MRVI 35.37
- Support Level
- DDL $3.30
- MRVI $4.05
- Resistance Level
- DDL $3.60
- MRVI $4.40
- Average True Range (ATR)
- DDL 0.16
- MRVI 0.31
- MACD
- DDL 0.05
- MRVI -0.05
- Stochastic Oscillator
- DDL 77.27
- MRVI 15.38
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.